Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets
制剂 FDF · Sustained-release Tablets · 12.5mg; 25mg
制剂 FDFConfidentiality：公开
- INN / Generic Name
- Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets
- Dosage Form
- Sustained-release Tablets
- Strength
- 12.5mg; 25mg
- Therapy Area
- Others > Psychiatry
- Indication
- Major depressive disorder; panic disorder; social anxiety disorder; premenstrual dysphoric disorder
- Current Status
- 官方 FDF 授权目录（UB205）
- GMP Certification
- US - FDA; CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 已完成注册（目标市场可转移 / 视市场 DCP·NP）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
United States
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —